lactic acid has been researched along with haloperidol in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (18.18) | 18.2507 |
2000's | 11 (50.00) | 29.6817 |
2010's | 7 (31.82) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
McLoughlin, JV; Wheatley, AM | 1 |
Dijk, S; Korf, J; Krugers, HJ | 1 |
Castagnoli, N; D'Engelbronner, J; Igarashi, K; Rollema, H; Skolnik, M; Usuki, E | 1 |
Fauconneau, B; Huguet, F; Piriou, A; Pontcharraud, R; Tallineau, C | 1 |
Bergh, JJ; Castagnoli, N; Mienie, LJ; Petzer, JP; Van der Schyf, CJ | 1 |
Messer, HH; Palamara, D; Palamara, JE; Pintado, M; Tyas, MJ | 1 |
Budhian, A; Siegel, SJ; Winey, KI | 3 |
Dan, N; Kahn, JB; Metzger, K; Siegel, SJ; Werner, K; Winey, KI | 1 |
Dan, N; Hans, M; Kahn, JB; Kanes, SJ; Liang, Y; Lowman, AM; Maxwell, CR; Metzger, KL; Shoemaker, JM; Siegel, SJ; Swerdlow, NR; Tokarczyk, J; Winey, KI | 1 |
Chan, SY; Chan, YW; Fan, SK; Ho, PC; Kang, L; Poh, AL | 1 |
Eppley, BL; Pietrzak, WS | 1 |
Deep-Soboslay, A; Halim, ND; Herman, MM; Hyde, TM; Kleinman, JE; Lipska, BK; Saylor, EM; Thakar, J; Verma, A | 1 |
Chan, SY; Fathi-Azarbayjani, A | 1 |
Dodig, T; Glavina, G; Glavina, T; Mrass, D; Pranić, S; Uglešić, B | 1 |
Cass, AE; Michelakis, K; Moniz, AR; Sharma, S; Trzebinski, J; Zhang, Y | 1 |
Ahmed, TA; Hussain, MD; Ibrahim, F; Ibrahim, HM; Kaseem, A; Nutan, MT; Samy, AM | 1 |
Bar-Shalom, D; Edinger, M; Genina, N; Rantanen, J | 1 |
Chantasart, D; Rakkaew, P; Suksiriworapong, J | 1 |
1 trial(s) available for lactic acid and haloperidol
Article | Year |
---|---|
Blood lactate levels in patients receiving first- or second- generation antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dopamine Antagonists; Drug Monitoring; Haloperidol; Humans; Lactic Acid; Male; Middle Aged; Movement Disorders; Olanzapine; Parkinson Disease, Secondary; Psychiatric Status Rating Scales; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2011 |
21 other study(ies) available for lactic acid and haloperidol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
The effect of haloperidol, spiperone and dantrolene on the concentrations of creatine phosphate, ATP and lactate in brain and skeletal muscle of the rat during halothane anesthesia.
Topics: Adenosine Triphosphate; Anesthesia; Animals; Antipsychotic Agents; Brain Chemistry; Dantrolene; Female; Haloperidol; Halothane; Lactates; Lactic Acid; Muscles; Phosphocreatine; Rats; Rats, Inbred Strains; Spiperone | 1991 |
The effect of theophylline and immobilization stress on haloperidol-induced catalepsy and on metabolism in the striatum and hippocampus, studied with lactography.
Topics: Adrenalectomy; Animals; Catalepsy; Corpus Striatum; Haloperidol; Hippocampus; Immobilization; Lactates; Lactic Acid; Male; Rats; Rats, Inbred Strains; Stress, Physiological; Theophylline | 1991 |
MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dopamine; Haloperidol; Lactates; Lactic Acid; Male; Mice; Microdialysis; Mitochondria, Liver; Nervous System; Pyridinium Compounds; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Serotonin; Serotonin | 1994 |
Evidence of lipoperoxidation induced by lactic acid on kidney homogenates.
Topics: Animals; Dose-Response Relationship, Drug; Haloperidol; Kidney Cortex; Lactates; Lactic Acid; Lipid Peroxidation; Male; Rats; Rats, Sprague-Dawley | 1993 |
Metabolic defects caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and by HPTP (the tetrahydropyridinyl analog of haloperidol), in rats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antipsychotic Agents; Haloperidol; Lactic Acid; Male; Metabolism, Inborn Errors; Mitochondria; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Valerates | 2000 |
Effect of stress on acid dissolution of enamel.
Topics: Analysis of Variance; Bicuspid; Bite Force; Dental Enamel; Dental Enamel Solubility; Epoxy Resins; Humans; Hydrogen-Ion Concentration; Immersion; Lactic Acid; Microscopy, Electron, Scanning; Replica Techniques; Statistics as Topic; Stress, Mechanical; Tooth Cervix; Water; Weight-Bearing | 2001 |
Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol.
Topics: Delayed-Action Preparations; Drug Compounding; Haloperidol; Lactic Acid; Nanotechnology; Nanotubes; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers | 2005 |
Effect of drug type on the degradation rate of PLGA matrices.
Topics: Anti-Inflammatory Agents; Antipsychotic Agents; Aspirin; Biocompatible Materials; Corticosterone; Delayed-Action Preparations; Diffusion; Drug Carriers; Haloperidol; Hydrochlorothiazide; Hydrolysis; Ibuprofen; Kinetics; Lactic Acid; Models, Chemical; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility; Thiothixene; Time Factors | 2006 |
Pharmacokinetic and behavioral characterization of a long-term antipsychotic delivery system in rodents and rabbits.
Topics: Acoustic Stimulation; Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Arousal; Biocompatible Materials; Drug Implants; Haloperidol; Inhibition, Psychological; Lactic Acid; Long-Term Care; Male; Mice; Mice, Inbred C57BL; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits; Rats; Rats, Sprague-Dawley; Reflex, Startle | 2007 |
Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
Topics: Delayed-Action Preparations; Diffusion; Drug Carriers; Emulsions; Haloperidol; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Lactic Acid; Molecular Weight; Nanoparticles; Nanotechnology; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility; Solvents; Sonication | 2007 |
Reversible effects of permeation enhancers on human skin.
Topics: Administration, Cutaneous; Algorithms; Antipsychotic Agents; Chemistry, Pharmaceutical; Cyclohexane Monoterpenes; Epidermis; Ethanol; Female; Haloperidol; Humans; Injections, Intramuscular; Lactic Acid; Monoterpenes; Nonlinear Dynamics; Pharmaceutical Vehicles; Propylene Glycol; Skin; Skin Absorption; Solvents | 2007 |
An experimental study of heat adaptation of bioabsorbable craniofacial meshes and plates.
Topics: Absorbable Implants; Biocompatible Materials; Bone Plates; Bone Substitutes; Buffers; Elasticity; Epoxy Resins; Equipment Design; Glass; Hot Temperature; Humans; Lactic Acid; Materials Testing; Models, Anatomic; Phase Transition; Pliability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Prosthesis Design; Surface Properties; Surgical Mesh; Temperature; Time Factors; Transition Temperature | 2007 |
Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles.
Topics: Chitosan; Gelatin; Haloperidol; Hydrophobic and Hydrophilic Interactions; Lactic Acid; Models, Chemical; Nanoparticles; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Surface Properties | 2008 |
Increased lactate levels and reduced pH in postmortem brains of schizophrenics: medication confounds.
Topics: Animals; Antipsychotic Agents; Artifacts; Brain; Brain Chemistry; Brain Diseases, Metabolic; Cerebellum; Clozapine; Confounding Factors, Epidemiologic; Energy Metabolism; Haloperidol; Humans; Hydrogen-Ion Concentration; Lactic Acid; Male; Postmortem Changes; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Schizophrenia; Up-Regulation | 2008 |
Single and multi-layered nanofibers for rapid and controlled drug delivery.
Topics: beta-Cyclodextrins; Delayed-Action Preparations; Electrochemistry; Haloperidol; Lactic Acid; Nanofibers; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol | 2010 |
Microfluidic device to investigate factors affecting performance in biosensors designed for transdermal applications.
Topics: Biosensing Techniques; Dimethylpolysiloxanes; Electrochemical Techniques; Epoxy Resins; Glucose; Glucose Oxidase; Lactic Acid; Membranes, Artificial; Microfluidic Analytical Techniques; Mixed Function Oxygenases; Polyurethanes | 2012 |
Development of biodegradable in situ implant and microparticle injectable formulations for sustained delivery of haloperidol.
Topics: Absorbable Implants; Animals; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Delivery Systems; Drug Stability; Haloperidol; Injections; Lactic Acid; Male; Molecular Weight; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Sprague-Dawley; Solvents | 2012 |
Visualization and Non-Destructive Quantification of Inkjet-Printed Pharmaceuticals on Different Substrates Using Raman Spectroscopy and Raman Chemical Imaging.
Topics: Chromatography, High Pressure Liquid; Dosage Forms; Ethanol; Haloperidol; Lactic Acid; Least-Squares Analysis; Pharmaceutical Preparations; Precision Medicine; Principal Component Analysis; Printing; Quality Control; Spectrum Analysis, Raman; Tablets; Technology, Pharmaceutical | 2017 |
β-Cyclodextrin-based ternary complexes of haloperidol and organic acids: the effect of organic acids on the drug solubility enhancement.
Topics: Antipsychotic Agents; beta-Cyclodextrins; Drug Carriers; Drug Compounding; Haloperidol; Lactic Acid; Solubility; Succinic Acid; Tartrates; Water | 2018 |